ClinicalTrials.gg
RecruitingNCT07629388FEM-COMBUpdated Oct 5, 2026

Combined Distal Femoral Nerve Block for Pain Control After Knee Replacement

An interventional study of Combined distal femoral nerve block and Saphenous nerve block alone in Pain After Total Knee Arthroplasty and Pain Management, sponsored by GCS Ramsay Santé pour l'Enseignement et la Recherche. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-05.

Sponsored by GCS Ramsay Santé pour l'Enseignement et la Recherche · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Started May 2026; still recruiting 5 months later.
Updated Oct 5, 2026Now RecruitingSite recruiting status changed+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
240
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 103 studies in Pain, Postoperative with a site in France — 18 open to participants now, 21 under way, 3 of them phase 3. Pain, Postoperative · France.

Planned enrollment
21st of 83
240 · median 140
Started
2026
with 7 others
No phase
41 of 103
11 open now
Primary completion
2027-05
later than 8 of 20 live
Registered
92nd of 103
by date
Lead sponsor
3 of 103
GCS Ramsay Santé pour l'Enseignement et la Recherche

Among the 103 studies in Pain, Postoperative with a site in France, this one is the 21st largest by planned enrollment of the 83 interventional ones that give a count, is one of 8 that started in 2026, is one of 41 with no phase, reaches primary completion later than 8 of the 20 other live ones, and was the 92nd registered.

Pain, Postoperative

5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.

Browse Pain, Postoperative studies →

Open to participants now

18 of the 103 studies in Pain, Postoperative with a site in France are open now. Recruiting first, the newest first:

12 more — sign in →

All 18 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 103 studies in Pain, Postoperative with a site in France, or all of them as a file.
02

Study summary

The goal of this clinical trial is to see whether a combined distal femoral nerve block improves pain relief after total knee replacement in adults having planned surgery. The main questions it aims to answer are:

  • Does the combined distal femoral nerve block reduce the amount of opioid needed in the post-anesthesia recovery room?
  • Does it preserve quadriceps muscle strength while improving postoperative pain control?

Researchers will compare the combined distal femoral nerve block to a saphenous nerve block alone to see if the combined block provides better analgesia without reducing leg strength.

Participants will:

  • Receive either the combined distal femoral nerve block or the saphenous nerve block alone before surgery.
  • Also receive standard multimodal pain management, including anesthesia, surgical site infiltration, and postoperative pain medications.
  • Be assessed for pain, opioid use, nausea and vomiting, quadriceps strength, time to first standing, hospital stay length, and patient satisfaction from surgery until discharge.
03

Conditions studied

  • Pain After Total Knee Arthroplasty
  • Pain Management

Browse trials for

Keywords

  • total knee arthroplasty
  • distal femoral nerve block
  • saphenous nerve block
  • femoral triangle block
  • postoperative pain
  • opioid consumption
  • regional anesthesia
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult patients aged over 18 years.
  • Scheduled for total knee arthroplasty with multimodal analgesia.
  • Affiliated with or benefiting from a social security system.
  • Able to understand the study information and provide written .

Exclusion criteria

Exclusion Criteria:

  • Emergency surgery.
  • Weight under 50 kg.
  • over 40 kg/m².
  • to nefopam, non-steroidal anti-inflammatory drugs, local anesthetics, or morphine.
  • Preoperative opioid use.
  • Antidepressant or gabapentinoid treatment.
  • Other planned surgical or medical procedures during the study period.
  • Participation in another clinical trial, or currently in an exclusion period from another trial.
  • Inability to understand study information for linguistic, psychological, cognitive, or literacy reasons.
  • Pregnancy, possible pregnancy without effective , or breastfeeding.
  • Protected adults, including those under guardianship, curatorship, legal protection, detention, or otherwise unable to give .
Terms in these criteria, in plain language(4)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

Contraception

Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.

Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
240 participants (estimated)

Study arms

  • Experimental
    Combined Distal Femoral Nerve Block

    Participants receive an ultrasound-guided combined distal femoral nerve block targeting the saphenous nerve, vastus medialis nerve, and anterior femoral cutaneous nerves, using ropivacaine 2 mg/mL, 40 mL total, with clonidine 30 micrograms perineural and dexamethasone 8 mg IV. They also receive surgical site infiltration, general anesthesia, and standard multimodal analgesia.

    Procedure: Combined distal femoral nerve block · Procedure: Standard perioperative care in both groups

  • Active comparator
    Saphenous Nerve Block Alone

    Participants receive an ultrasound-guided saphenous nerve block at the adductor canal using ropivacaine 2 mg/mL, 20 mL total, with clonidine 30 micrograms perineural and dexamethasone 8 mg IV. They also receive surgical site infiltration, general anesthesia, and standard multimodal analgesia.

    Procedure: Saphenous nerve block alone · Procedure: Standard perioperative care in both groups

Interventions

  • ProcedureCombined distal femoral nerve block

    Ultrasound-guided block targeting the saphenous nerve, vastus medialis nerve, and anterior femoral cutaneous nerves, using ropivacaine 2 mg/mL, 40 mL total, with clonidine 30 micrograms perineural and dexamethasone 8 mg IV.

  • ProcedureSaphenous nerve block alone

    Ultrasound-guided saphenous nerve block at the adductor canal, using ropivacaine 2 mg/mL, 20 mL total, with clonidine 30 micrograms perineural and dexamethasone 8 mg IV.

  • ProcedureStandard perioperative care in both groups

    General anesthesia, surgical site infiltration, and multimodal analgesia with paracetamol, nefopam, and ketoprofen.

06

What researchers measure

Primary outcomes

  1. Postoperative Opioid Consumption in post-anesthesia care unit (PACU).

    Total amount of opioids consumed in the post-anesthesia care unit, converted into oral morphine equivalent.

    Time frame: From arrival in PACU until discharge from PACU, on postoperative day 0.

Secondary outcomes

  1. Pain During Regional Anesthesia

    Pain experienced during the performance of the locoregional anesthesia, assessed using a 10-point visual analog scale (VAS), in which 0 indicates no pain and 10 indicates maximal pain.

    Time frame: During block administration on postoperative day 0.

  2. Postoperative Pain in post-anesthesia care unit (PACU) and Ward

    Pain intensity measured with a 10-point visual analog scale (VAS), in which 0 indicates no pain and 10 indicates maximal pain.

    Time frame: Twice in PACU on postoperative day 0 after extubation and before PACU discharge; three times on postoperative day 1; and at hospital discharge (up to 7 days).

  3. Quadriceps Motor Strength

    Quadriceps motor strength will be assessed using the Medical Research Council muscle strength scale, ranging from 0 to 5, where 0 indicates no visible contraction and 5 indicates normal strength; higher scores indicate better motor strength. Ability to perform an active straight-leg raise will be recorded as yes/no, and quadriceps tone will be clinically assessed for hypotonia, flaccidity, or contracture.

    Time frame: Postoperative day 0 in PACU and postoperative day 1.

  4. Time to First Standing

    Delay until first mobilization/first standing after surgery.

    Time frame: Postoperative day 0.

  5. Postoperative Nausea and Vomiting

    Incidence of postoperative nausea and vomiting in post-anesthesia care unit (PACU).

    Time frame: Postoperative day 0 in post-anesthesia care unit (PACU).

  6. Oral Opioid Consumption on the Ward

    Total oral opioid use during hospitalization, reported as oral morphine equivalent.

    Time frame: Postoperative day 1 and until hospital discharge (up to 7 days).

  7. Co-analgesic Consumption

    Use of co-analgesics including nefopam, paracetamol, opium, and ketoprofen during hospitalization.

    Time frame: Postoperative day 1 and until hospital discharge (up to 7 days).

  8. Intraoperative Medication Use

    Consumption of hypotensive drugs, vasopressors, and opioids during surgery.

    Time frame: Intraoperative period on postoperative day 0.

  9. Length of Hospital Stay

    Duration of hospitalization after surgery.

    Time frame: At hospital discharge, up to 7 days after surgery.

  10. Patient Satisfaction

    Patient satisfaction will be assessed using the Evaluation du Vécu de l'Anesthésie Générale (EVAN-G), a validated 26-item self-administered perioperative satisfaction questionnaire. The EVAN-G includes six dimensions: attention, privacy, information, pain, discomfort, and waiting times. The global satisfaction index score ranges from 0 to 100, where 0 indicates the worst possible level of satisfaction and 100 indicates the best possible level of satisfaction; higher scores indicate greater patient satisfaction.

    Time frame: At hospital discharge, up to 7 days after surgery.

07

Study locations

1 of 1 sites recruiting
08

References and documents

Publications

  • Maurice-Szamburski A. Le vécu périopératoire du patient, un nouveau paradigme ? Le Praticien en Anesthésie Réanimation. déc 2017;21(6):285-9.
  • Mahdy EW, Abd El-Hamid AM, Elbarbary DH. Comparison between adductor canal block and femoral nerve block for different knee surgical procedures. A meta-analysis of randomized trials. Egyptian Journal of Anaesthesia. janv 2021;37(1):491-500.
  • Tarpin P, Fumery O, Radji M, Martinez V. La chronicisation de la douleur en anesthésie-réanimation. Anesthésie & Réanimation. mars 2025;11(1):36-45.
  • Auquier P, Pernoud N, Bruder N, Simeoni MC, Auffray JP, Colavolpe C, Francois G, Gouin F, Manelli JC, Martin C, Sapin C, Blache JL. Development and validation of a perioperative satisfaction questionnaire. Anesthesiology. 2005 Jun;102(6):1116-23. doi: 10.1097/00000542-200506000-00010. PubMed 15915023 ↗
  • Wylde V, Bertram W, Sanderson E, Noble S, Howells N, Peters TJ, Beswick AD, Blom AW, Moore AJ, Bruce J, Walsh DA, Eccleston C, Harris S, Garfield K, White S, Toms A, Gooberman-Hill R; STAR trial group. The STAR care pathway for patients with pain at 3 months after total knee replacement: a multicentre, pragmatic, randomised, controlled trial. Lancet Rheumatol. 2022 Jan 28;4(3):e188-e197. doi: 10.1016/S2665-9913(21)00371-4. eCollection 2022 Mar. PubMed 35243362 ↗
  • Mei S, Jin S, Chen Z, Ding X, Zhao X, Li Q. Analgesia for total knee arthroplasty: a meta-analysis comparing local infiltration and femoral nerve block. Clinics (Sao Paulo). 2015 Sep;70(9):648-53. doi: 10.6061/clinics/2015(09)09. PubMed 26375568 ↗
  • Gadsden JC, Sata S, Bullock WM, Kumar AH, Grant SA, Dooley JR. The relative analgesic value of a femoral nerve block versus adductor canal block following total knee arthroplasty: a randomized, controlled, double-blinded study. Korean J Anesthesiol. 2020 Oct;73(5):417-424. doi: 10.4097/kja.20269. Epub 2020 Aug 26. PubMed 32842722 ↗
  • Kuang MJ, Ma JX, Fu L, He WW, Zhao J, Ma XL. Is Adductor Canal Block Better Than Femoral Nerve Block in Primary Total Knee Arthroplasty? A GRADE Analysis of the Evidence Through a Systematic Review and Meta-Analysis. J Arthroplasty. 2017 Oct;32(10):3238-3248.e3. doi: 10.1016/j.arth.2017.05.015. Epub 2017 May 17. PubMed 28606458 ↗
  • Wang D, Yang Y, Li Q, Tang SL, Zeng WN, Xu J, Xie TH, Pei FX, Yang L, Li LL, Zhou ZK. Adductor canal block versus femoral nerve block for total knee arthroplasty: a meta-analysis of randomized controlled trials. Sci Rep. 2017 Jan 12;7:40721. doi: 10.1038/srep40721. PubMed 28079176 ↗
  • Elkassabany NM, Antosh S, Ahmed M, Nelson C, Israelite C, Badiola I, Cai LF, Williams R, Hughes C, Mariano ER, Liu J. The Risk of Falls After Total Knee Arthroplasty with the Use of a Femoral Nerve Block Versus an Adductor Canal Block: A Double-Blinded Randomized Controlled Study. Anesth Analg. 2016 May;122(5):1696-703. doi: 10.1213/ANE.0000000000001237. PubMed 27007076 ↗
  • Andersen LO, Gaarn-Larsen L, Kristensen BB, Husted H, Otte KS, Kehlet H. Subacute pain and function after fast-track hip and knee arthroplasty. Anaesthesia. 2009 May;64(5):508-13. doi: 10.1111/j.1365-2044.2008.05831.x. PubMed 19413820 ↗
  • Nicolino TI, Costantini J, Carbo L. Complementary Saphenous Nerve Block to Intra-Articular Analgesia Reduces Pain After Total Knee Arthroplasty: A Prospective Randomized Controlled Trial. J Arthroplasty. 2020 Jun;35(6S):S168-S172. doi: 10.1016/j.arth.2020.03.010. Epub 2020 Mar 12. PubMed 32253065 ↗
  • Knecht S, Tamine L, Faure N, Tran P, Orban JC, Bronsard N, Gonzalez JF, Micicoi G. Effectiveness of adductor canal block combined with posterior capsular infiltration on pain and return to walking after total knee arthroplasty: comparative analysis with femoral and popliteal sciatic nerves blocks. Orthop Traumatol Surg Res. 2025 Sep;111(5):104082. doi: 10.1016/j.otsr.2024.104082. Epub 2024 Dec 5. PubMed 39645191 ↗
  • Beswick AD, Wylde V, Gooberman-Hill R, Blom A, Dieppe P. What proportion of patients report long-term pain after total hip or knee replacement for osteoarthritis? A systematic review of prospective studies in unselected patients. BMJ Open. 2012 Feb 22;2(1):e000435. doi: 10.1136/bmjopen-2011-000435. Print 2012. PubMed 22357571 ↗
  • Glare P, Aubrey KR, Myles PS. Transition from acute to chronic pain after surgery. Lancet. 2019 Apr 13;393(10180):1537-1546. doi: 10.1016/S0140-6736(19)30352-6. PubMed 30983589 ↗

Individual participant data

Plan to share: Yes — De-identified individual participant data underlying the results reported in the published article will be made available, together with the study protocol and statistical analysis plan, after publication of the main results. Data sharing will be subject to sponsor approval, a methodologically sound proposal, signature of a data access agreement, and compliance with GDPR.

Supporting information: Study protocol, Statistical analysis plan

Time frame: Beginning 6 months and ending 36 months after publication of the main results

Access criteria: Requests should be addressed to the corresponding author and will be reviewed by the sponsor; data will be shared with researchers providing a methodologically sound proposal, after signature of a data access agreement and in compliance with GDPR.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2026 (actual). Primary completion is estimated for May 2027, 11 months after the start.

Of 2,113 non-industry interventional studies with no phase under Pain, Postoperative, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's planned 11 months is close to that.

Counting every sponsor, half of 2,126 studies reached it within 11 months; a quarter within 6 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
May 27, 2026
First posted
Jun 5, 2026
StartActual
May 26, 2026
Primary completionEst.
May 25, 2027
CompletionEst.
May 25, 2027
Last update
Oct 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Recruiting
changed Oct 5, 2026
Sites
Hôpital privé Dijon Bourgogne is now Recruiting
Oct 5, 2026
Start date
May 25, 2026→May 26, 2026 (actual)
Oct 5, 2026
Show all 1 update
  1. Oct 5, 2026
    Not yet recruiting→Recruiting
    Hôpital privé Dijon Bourgogne is now Recruiting
    Start date May 25, 2026→May 26, 2026 (now actual)

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07629388
Responsible party
Sponsor
First posted
Jun 5, 2026
Start date
May 26, 2026
Primary completion
May 25, 2027 (estimated)
Completion
May 25, 2027 (estimated)
Last update
Oct 5, 2026

Study contacts

Antoine Sanchez
Contact
sanchez.antoine@live.fr
+33 3 80 40 01 14
Antoine Sanchez, MD
principal investigator · Hôpital privé Dijon Bourgogne

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion